Coronary artery disease (CAD) remains a major global health problem, although levels of risk factors have been reduced in some Western countries. In particular, smoking is decreasing and there is an increasing focus on healthy diets and exercise. Recently, the cross sectional European Society of Cardiology European Action on Secondary and Primary Prevention by Intervention to Reduce Events (EUROASPIRE) III and IV surveys reported an increase in vigorous physical activity (20 min, three times per week or more) from 14.1% to 20.2% (p < 0.001). 1, 2 However, cardiac rehabilitation with exercise training (ET) is still an underused therapy. 3 This might be due to lack of knowledge about the benefits of ET as suggested by the American Heart Association, 4 or insufficient evidence of benefit. Most of the studies have been performed in the 1980s and 1990s in selected populations. Therefore, the effect of ET on top of contemporary drug and revascularization therapies has been questioned.
Current recommendations
The 2016 European Guidelines on cardiovascular disease prevention in clinical practice recommend physical activity (PA) including strength training and aerobic endurance training at least 3-4 times a week. 5 Interval training with 2-3 rounds consisting of 10-12 repetitions at 60-80% of maximal capacity has also been recommended. On the other hand, aerobic interval training or high-intensity interval training is not broadly recommended until further data on safety and efficacy are available. Only aerobic ET alone or in combination with other modalities has a 1A indication.
In the current guidelines for stable CAD, patients are encouraged to exercise at least 30 min for three times per week to improve prognosis. 6, 7 In the recent guidelines on non-ST-segment myocardial infarction (N-STEMI), participation in a structured rehabilitation program with exercise training has a 2a indication (that weight of evidence/opinion is in favour of usefulness/ efficacy). It is recommended to advise all patients on lifestyle changes (including smoking cessation, regular physical activity and a healthy diet). [8] [9] [10] In the current European Society of Cardiology (ESC) heart failure guidelines ET per se has a 1A indication. 11
Rationale for exercise training
The recommendations in the guidelines are based on positive effects on prognosis documented in metaanalyses, pooled cohort analysis and longitudinal follow-up. [12] [13] [14] ET has also been documented to reduce weight, improve endothelial function, improve glucose metabolism, improve coronary microcirculation 15 and increase cardiorespiratory fitness. Even more important, improved physical capacity is also associated with improved quality of life because of better energetics and increased walking distance without limiting symptoms. The positive impact of ET on anxiety and depression has also been demonstrated in several smaller studies. 16 The importance of coping with CVD after participating in ET training programmes together with peers in a safe environment is well documented. 17 In addition, shock anxiety and depression in ICD recipients might be reduced after participating in a grouptraining programme. 18 The increase in cardiorespiratory fitness is associated with improved prognosis. 19 This is in accordance with observational studies which have consistently shown that a low level of PA is associated with increased risk of all-cause mortality and cardiovascular morbidity both in the general population 12, 13 and in patients with CVD. 20 However, most of the data supporting aerobic ET are based on single-centre studies conducted before the primary percutaneous coronary intervention (PCI) and the primary implantable cardioverter defibrillator (ICD) era.
More recently a single-centre pilot study demonstrated a considerable improvement in left ventricular performance associated with improved aerobic capacity, after a 12-week aerobic high intensity-training programme in heart failure. 21 Unfortunately these beneficial effects on left ventricular function could not be fully confirmed in the following randomised controlled trial (RCT), Study of MyocArdial Recovery afTer EXercise training in Heart Failure (SMARTEX) that was recently published in Circulation. 22 Another large multi-centre RCT in heart failure, Heart Failure: A Controlled Trial Investigating Outcomes of Exercise Training (HF ACTION), showed no significant improvement in hard endpoints before statistical adjustments were performed. 23 On the other hand, in a coronary artery disease RCT, Hambrecht and co-workers showed an improved effect of ET on major adverse cardiac event (MACE) compared to PCI in a small population with CAD and significant stenosis. However, this was well before the use of fractional flow reserve (FFR) to assess ischaemia. Similarly, in a long-term Italian study on ET in heart failure the positive effects with improved left ventricular ejection function (LVEF) at 10 years of follow-up are also documented. 24 All of these studies have mainly used endurance training as intervention. However, recently Pattyn and co-workers even showed long-term effects after both an aerobic continuous ET programme and a aerobic interval training programme. 25 
Strength training
Until recently, no large studies have evaluated the effect strength training per se as a sole intervention or as a part of a combined ET programme on cardiorespiratory fitness and muscular strength. As for aerobic ET, there are multiple smaller studies indicating the beneficial effects of strength training. This includes improved bone formation and reduced bone loss, preserved and enhanced muscle mass, strength, power and functional ability. 26 In addition, there are indications of benefit in lipid and blood pressure control and insulin sensitivity, especially in combination with aerobic exercise. 27 Moreover Shaw and Shaw showed that strength training per se is improving peak oxygen volume (VO 2 ) in healthy young individuals. 28 This was further confirmed in patients with CAD by Pierson and coworkers who found that resistance training adds to the effects of aerobic training by improving muscular strength, increasing body lean mass and reducing body fat in patients with CAD. 29 On the other hand Currie and co-workers demonstrated no additional effect of strength training after a programme of aerobic training (AT) in patients with stable CAD. 30 Muscular strength per se is also of prognostic significance. Maximal quadriceps isometric strength (QIS) is related with estimated metabolic equivalents (eMETs) levels reached at exercise testing in CAD patients, and has identified maximal QIS cut-off values for eMETs prediction. 31 Despite the positive data accumulating, the recommendations in the current guidelines with respect to strength training per se are rather vague. This is partly due to the lack of larger RCTs and meta-analyses.
Current study
It is therefore of vital importance when, in a recent issue of the journal, Hollings and co-workers 39 report the results of a meta-analysis of randomised trials that examined the effect and safety of progressive resistance training (PRT) on cardiorespiratory fitness and muscular strength compared to control (CT), AT or PRT in combination with AT.
The authors screened all relevant studies published using strict search criteria employing a modified version of the Physiotherapy Evidence Database (PEDro) scale. In addition they used three important criteria including supervised ET by a qualified health or medical professional, program characteristics including duration, session frequency, number of exercises, volume, intensity and type of resistance used, and program adherence. In this way the authors seem to avoid limitations in previous meta-analyses with inadequate search sensitivity, poor or improper definitions of intervention and control group and unclear statistical methods.
Primary outcome measures were muscular strength and cardiorespiratory fitness (CRF). After quality assessment, 34 trials including 1940 participants were included in the analyses. The studies included in the meta-analysis were published from 1982-2015 with 19 studies registered before 2000. They are all studies of small numbers, and there are comparisons with different types of endurance training from walking at 70% of maximum heart rate (HRmax) to arm cycling and breathing relaxation exercises. Intervention programs varied from 3-26 weeks in duration and consisted of 2-5 exercise sessions per week. The interventions were described to be mainly machine-based, isotonic, wholebody, multi-joint movements. The intensities and length of the programmes are thus very heterogeneous. Most control groups were prescribed no structured exercise-training programme, but it was recommended to the patients to maintain usual physical activity levels.
In the AT arm the mode, intensity and duration varied considerably. Only one study employed high intensity interval training, whereas the rest were endurance programmes in which the sessions ranged from 60-95% HR max and 18-90 min in duration.
There were few adverse events, and only five patients were excluded from continued intervention. One would have expected some more adverse events. In some of the studies included this is not reported at all. Another problem with large meta-analyses is the lack of information about the diagnosis of CAD. In patients suffering from a myocardial infarction (MI) or who have undergone Coronary artery bypass grafting (CABG) the diagnosis is clear. In stable patients with angina the diagnosis of CAD is depending on perfusion stress test modalities or invasive assessment with fractional flow reserve (FFR) in addition to imaging modalities of the coronary arteries to confirm the existence of atherosclerosis. The secondary prophylaxis with ET in patients with angiographically documented atherosclerosis is therefore dependent on a negative stress test and an assessment of LVEF to avoid serious adverse events during ET. Additionally, LVEF is one of the most important prognostic factors in addition to age. Another important issue is the occurrence of sudden cardiac arrest (SCA) or malignant arrhythmias, which is very seldom reported in ET studies.
Overall quality of the included studies was reported to be moderate, with a mean PEDro score of 5 AE 1 with only seven studies considered to be of high quality. Common limitations were reported to be lack of allocation concealment, subject, therapist and assessor blinding and intention-to-treat analysis. Adherence reporting was poor, whereas PRT dose and exercise supervision were more commonly reported. Only 70% of the studies included reported medication use.
Despite these obvious weaknesses in the studies included in this meta-analysis, the authors could show an effect of PRT on CRF both as a lone-standing intervention and combined with AT. In the analyses of PRT compared with control the significant heterogeneity meant it was not suitable to pool overall. On the other hand PRT compared to AT showed a similar increase in CRF (15.6% and 20.1% increase respectively) with no statistical significant difference in peak VO 2 or work capacity. In addition combined training resulted in a significantly greater improvement in peak work capacity compared to AT.
When it comes to muscular strength there was an overwhelming effect of PRT compared to controls. PRT compared to AT was evaluated in two studies only, and the results were opposite in these studies. More interestingly, but as suspected, there was also a much larger effect on muscular strength with combined training compared to AT alone.
Comparison with previous meta-analyses
The positive findings in the current study is in accordance with the findings in a recently published metaanalysis on studies comparing AT with the combination of strength training and AT in which the investigators found that the later gave a statistically significant increased improvement in physical capacity including peak VO 2 . 32 The current study is also in accordance with a previous meta-analyses on AT compared with resistance training (RT), in which Marzolin and co-workers found that combined AT and RT (CT) was more effective than AT when it comes to body composition improvement, strength and some indicators of CRF. In addition there were no excess in adverse events in the CT group. 33 The findings in the current study add to the bulk of evidence indicating the obvious benefits of PRT. The increase in peak VO 2 and CRF is an indication of improved functional capacity during daily living and is also indicating improved prognosis. The improvement in muscular strength is an important part of increased VO 2 in addition to the obvious effects on daily living with better energetics.
The authors should be congratulated on this comprehensive review and meta-analysis demonstrating that PRT per se is a valuable training approach that could be used over the whole spectrum of cardiovascular rehabilitation. PRT provides improvements in CRF that are comparable to AT in adults with CAD. Moreover they have shown that the addition of PRT to AT programmes further improves both fitness and strength significantly more compared to AT alone. This important work underlines the necessity of combining several training modalities to improve symptoms and prognosis in this large population of patients with CVD.
Few if any randomised trials have been able to document the effect of ET on hard endpoints in CAD. However, the positive findings in the current study are in accordance with the findings in a large Dutch population-based cohort study using an insurance claim database in the years 2007-2010. Patients with an acute coronary syndrome (ACS) or those who had undergone coronary revascularisation or valve surgery were included. Cardiac rehabilitation consisted of some type of group training, lifestyle modification therapy, relaxation therapy and education. After propensity score weighting the hazard ratio of receiving cardiac rehabilitation (CR) was 0.65 (95% CI 0.56-0.77). 34 The need for large randomised long-lasting studies
In CVD, there are few randomised trials published with positive effect on hard endpoints. In addition the programmes are almost always of very limited duration. We do not know if long-lasting ET programmes have a selection bias in that only the fittest individuals are continuing the programme.
Observational studies give clues about the relationships between physical activity (PA) and mortality and morbidity, but such studies cannot definitively establish that increasing PA promotes health and longevity, because people who are physically active may differ from inactive people in ways other than their level of PA. A primary source of potential residual confounding is likely to stem from variables that were either not recorded or insufficiently measured in previous studies. For instance, dietary intake was rarely assessed in the observational studies. Genetics is another important potential confounder. 35, 36 The challenges with CR programmes are also adherence, intensity and length of programme. The effects of ET have to be maintained. It is not a short-term intervention with permanent effects.
In a large systematic review on 47 studies and 10,794 patients with MI, CABG, PCI or angina assigned to exercise-based rehabilitation or usual care the investigators found a large reduction in total and cardiovascular mortality at 12 months, but no reduction in subsequent AMI, PCI or CABG. 37 Excluding a few studies described above, there are no large multicentre RCTs documenting the effect on hard endpoints in CVD. The obvious strength of an RCT is avoidance of confounding factors. There should not be a selection of patients and the intervention needs to be well defined and of adequate dose.
Therefore, because large randomised long-term studies are almost impossible to perform, the study by Hollings et al., who employed very strict criteria for inclusions in their analyses, is of vital importance for the understanding of the addition of strength training in ET programmes in the population with CAD.
However, there is still a gap in the bulk of evidence for the benefits of ET in CAD on hard endpoints including improved survival, as secondary prophylaxis in patients with CAD on optimal medical treatment in the post-PCI, post-ICD era. It is, therefore, time for a large RCT with long-term intervention including strength training both for additional effect and as an alternative training modality for patients who are not able to participate in ordinary ET programmes.
So far, higher-intensity AT programmes, supplemented by resistance training, have been recommended and deemed safe for cardiac rehabilitation patients by many authorities. Based on research evidence, these may also provide superior outcomes for patients and should therefore be considered when developing an international consensus for exercise prescription in cardiac rehabilitation. 38 
